These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 1778595)
1. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects. Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595 [TBL] [Abstract][Full Text] [Related]
2. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression. Sarne DH; Sobieszczyk S; Ain KB; Refetoff S J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573 [TBL] [Abstract][Full Text] [Related]
3. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man. Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487 [TBL] [Abstract][Full Text] [Related]
4. Effect of domperidone on prolactin (PRL)and thyrotrophin (TSH) secretion. Kaufman JM; Elewaut A; Vermeulen A Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):293-303. PubMed ID: 6802092 [TBL] [Abstract][Full Text] [Related]
5. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response. Snyder PJ; Utiger RD J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417 [TBL] [Abstract][Full Text] [Related]
7. Monoamine regulation of prolactin and TSH secretion in hypothyroidism. Gerasimov G; Chernova T; Goncharov N Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463 [TBL] [Abstract][Full Text] [Related]
8. Effect of rendering male rats hypothyroid at different stages of development on adenohypophysial hormone release. Sowers JR; Sollars E Horm Metab Res; 1980 Oct; 12(10):524-8. PubMed ID: 6777284 [TBL] [Abstract][Full Text] [Related]
9. [Hyperthyroidism and subjects hyperresponding to thyrotropin. Importance of simultaneous thyrotropin and prolactin determination following administration of thyroid-releasing hormone]. Schlienger JL; De Laharpe F; Reville P; Stephan F Sem Hop; 1980 May 8-15; 56(17-18):827-31. PubMed ID: 6248964 [TBL] [Abstract][Full Text] [Related]
10. Low thyroxine levels in some hyperprolactinemic patients due to dopaminergic suppression of thyrotropin. Holdaway IM; Evans MC; Sheehan A; Ibbertson HK J Clin Endocrinol Metab; 1984 Oct; 59(4):608-13. PubMed ID: 6434574 [TBL] [Abstract][Full Text] [Related]
11. The effect of dexamethasone on TSH and prolactin secretion after TRH stimulation. Dussault JH Can Med Assoc J; 1974 Dec; 111(11):1195-7. PubMed ID: 4215558 [TBL] [Abstract][Full Text] [Related]
12. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat. Harris AR; Christianson D; Smith MS; Fang SL; Braverman LE; Vagenakis AG J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840 [TBL] [Abstract][Full Text] [Related]
13. On the role of dopamine receptors in the central regulation of human TSH. Delitala G; Devilla L; Canessa A; D'Asta F Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients. Nedvídková J; Felt V Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434 [TBL] [Abstract][Full Text] [Related]
15. Central hypothyroidism--various types of TSH responses to TRH stimulation. Trejbal D; Sulla I; Trejbalová L; Lazúrová I; Schwartz P; Machánová Y Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012 [TBL] [Abstract][Full Text] [Related]
16. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. Coiro V; Butturini U; Gnudi A; Volpi R; d'Amato L; Speroni G; Capretti L; Roti E; Chiodera P Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134 [TBL] [Abstract][Full Text] [Related]
17. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect. Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271 [TBL] [Abstract][Full Text] [Related]
18. Prolactin as a marker of dopaminergic activity at different levels of thyroid function in man. Varela C; Cacicedo L; Santirso RA; Zurita P; Sanchez Franco F Horm Metab Res; 1984 Nov; 16(11):598-601. PubMed ID: 6510891 [TBL] [Abstract][Full Text] [Related]
19. Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man. Delitala G; Devilla L; Lotti G J Clin Endocrinol Metab; 1980 Jun; 50(6):1127-30. PubMed ID: 7372791 [TBL] [Abstract][Full Text] [Related]
20. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism. Felt V; Nedvdková J Horm Metab Res; 1977 Jul; 9(4):274-7. PubMed ID: 408253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]